EE200300300A - Kinasoliinderivaadid, neid ühendeid sisaldavad ravimid, nende kasutamine ja meetod nende valmistamiseks - Google Patents

Kinasoliinderivaadid, neid ühendeid sisaldavad ravimid, nende kasutamine ja meetod nende valmistamiseks

Info

Publication number: EE200300300A
Authority: EE; Estonia
Prior art keywords: compounds; preparation; quinazoline derivatives; drugs containing; drugs
Prior art date: 2000-12-20

Application number

EEP200300300A

Other languages

English (en)

Inventor

Himmelsbach Frank

Langkopf Elke

Blech Stefan

Jung Birgit

Baum Elke

Solca Flavio

Original Assignee

Boehringer Ingelheim Pharma Gmbh & Co. Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-20

Filing date

2001-12-12

Publication date

2003-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7667887&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200300300(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-12-12 Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg

2003-10-15 Publication of EE200300300A publication Critical patent/EE200300300A/et

2009-12-15 Publication of EE05244B1 publication Critical patent/EE05244B1/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

EEP200300300A 2000-12-20 2001-12-12 Kinasoliinderivaadid, neid hendeid sisaldavad ravimid, nende kasutamine ja meetod nende valmistamiseks EE05244B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10063435A DE10063435A1 (de)	2000-12-20	2000-12-20	Chinazolinderviate,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
PCT/EP2001/014569 WO2002050043A1 (de)	2000-12-20	2001-12-12	Chinazolinderivate, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung

Publications (2)

Publication Number	Publication Date
EE200300300A true EE200300300A (et)	2003-10-15
EE05244B1 EE05244B1 (et)	2009-12-15

Family

ID=7667887

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300300A EE05244B1 (et)	2000-12-20	2001-12-12	Kinasoliinderivaadid, neid hendeid sisaldavad ravimid, nende kasutamine ja meetod nende valmistamiseks

Country Status (39)

Country	Link
EP (2)	EP1345910B9 (et)
JP (1)	JP3827641B2 (et)
KR (1)	KR100852102B1 (et)
CN (1)	CN1277822C (et)
AR (1)	AR040524A1 (et)
AT (1)	ATE430136T1 (et)
AU (2)	AU2002219174B2 (et)
BE (1)	BE2014C009I2 (et)
BG (1)	BG66139B1 (et)
BR (1)	BRPI0116266B8 (et)
CA (1)	CA2432428C (et)
CY (2)	CY1109290T1 (et)
CZ (1)	CZ302721B6 (et)
DE (2)	DE10063435A1 (et)
DK (1)	DK1345910T3 (et)
EA (1)	EA006317B1 (et)
EE (1)	EE05244B1 (et)
ES (1)	ES2326617T3 (et)
FR (1)	FR14C0009I2 (et)
HR (1)	HRP20030504B1 (et)
HU (2)	HU228874B1 (et)
IL (2)	IL156277A0 (et)
LT (1)	LTC1345910I2 (et)
LU (1)	LU92370I2 (et)
ME (1)	ME02777B (et)
MX (1)	MXPA03005559A (et)
MY (1)	MY136086A (et)
NO (3)	NO325672B1 (et)
NZ (1)	NZ526918A (et)
PL (1)	PL214798B1 (et)
PT (1)	PT1345910E (et)
RS (1)	RS50860B (et)
SI (1)	SI1345910T1 (et)
SK (1)	SK287573B6 (et)
TW (1)	TWI295992B (et)
UA (1)	UA74614C2 (et)
UY (1)	UY27078A1 (et)
WO (1)	WO2002050043A1 (et)
ZA (1)	ZA200304141B (et)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA01012899A (es)	1999-06-21	2002-07-30	Boehringer Ingelheim Pharma	Heterociclos biciclicos, medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparacion.
US7019012B2 (en)	2000-12-20	2006-03-28	Boehringer Ingelheim International Pharma Gmbh & Co. Kg	Quinazoline derivatives and pharmaceutical compositions containing them
DE10204462A1 (de) *	2002-02-05	2003-08-07	Boehringer Ingelheim Pharma	Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse
US6924285B2 (en)	2002-03-30	2005-08-02	Boehringer Ingelheim Pharma Gmbh & Co.	Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
US20040044014A1 (en)	2002-04-19	2004-03-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
DE10221018A1 (de) *	2002-05-11	2003-11-27	Boehringer Ingelheim Pharma	Verwendung von Hemmern der EGFR-vermittelten Signaltransduktion zur Behandlung von gutartiger Prostatahyperplasie (BPH)/Prostatahypertrophie
PE20040945A1 (es) *	2003-02-05	2004-12-14	Warner Lambert Co	Preparacion de quinazolinas substituidas
US7223749B2 (en)	2003-02-20	2007-05-29	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
DE10307165A1 (de) *	2003-02-20	2004-09-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, ihre Verwendung und Verfahren zu ihrer Herstellung
US20050043233A1 (en)	2003-04-29	2005-02-24	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
DE10334226A1 (de) *	2003-07-28	2005-02-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse
GB0317665D0 (en)	2003-07-29	2003-09-03	Astrazeneca Ab	Qinazoline derivatives
ES2305844T3 (es)	2003-09-16	2008-11-01	Astrazeneca Ab	Derivados de quinazolina como inhibidores de tirosina cinasa.
US7456189B2 (en)	2003-09-30	2008-11-25	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
DE10349113A1 (de) *	2003-10-17	2005-05-12	Boehringer Ingelheim Pharma	Verfahren zur Herstellung von Aminocrotonylverbindungen
SI1746999T1 (sl) *	2004-05-06	2012-01-31	Warner Lambert Co	4-fenilamino-kinazolin-6-il-amidi
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
WO2006081741A1 (en) *	2005-02-05	2006-08-10	Piaoyang Sun	Quinazoline compounds or their medical salts and preparation and medical usage thereof
KR100832593B1 (ko) *	2005-11-08	2008-05-27	한미약품 주식회사	신호전달 저해제로서의 퀴나졸린 유도체 및 이의 제조방법
PL1948180T3 (pl)	2005-11-11	2013-09-30	Boehringer Ingelheim Int	Terapia skojarzona raka polegająca na podawaniu inhibitorów EGFR/HER2
CA2833706C (en)	2005-11-11	2014-10-21	Boehringer Ingelheim International Gmbh	Quinazoline derivatives for the treatment of cancer diseases
SI1981863T1 (sl)	2006-01-26	2013-01-31	Boehringer Ingelheim International Gmbh	Postopek za pripravo aminokrotonilamino-substituiranih kinazolinskih derivatov
RU2492864C2 (ru) *	2006-09-18	2013-09-20	Бёрингер Ингельхайм Интернациональ Гмбх	Способ лечения рака, несущего мутации egfr
EP1921070A1 (de)	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
US7998949B2 (en)	2007-02-06	2011-08-16	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof
BRPI0907916A2 (pt)	2008-02-07	2015-07-28	Boehringer Ingelheim Int	Heterociclos espirociclos, medicamentos contendo esses compostos, e processos para preparar os mesmos
WO2009138781A1 (en)	2008-05-13	2009-11-19	Astrazeneca Ab	Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxy}quinazoline
PE20100252A1 (es)	2008-06-06	2010-04-12	Boehringer Ingelheim Int	Nuevas formulaciones farmaceuticas solidas que comprenden dimaleato de 4-[(3-cloro-4-fluorofenil) amino]-6-{[4-(n,n-dimetilamino)-1-oxo-2-buten-1-il] amino}-7-((s)-tetrahidrofuran-3-iloxi)-quinazolina
US8426430B2 (en)	2008-06-30	2013-04-23	Hutchison Medipharma Enterprises Limited	Quinazoline derivatives
US8648191B2 (en)	2008-08-08	2014-02-11	Boehringer Ingelheim International Gmbh	Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
CN102264745B (zh) *	2008-11-10	2015-07-22	财团法人卫生研究院	作为酪胺酸激酶抑制剂的稠合双环及多环嘧啶化合物
EP2387401A1 (en)	2009-01-14	2011-11-23	Boehringer Ingelheim International GmbH	Method for treating colorectal cancer
AU2010212865A1 (en)	2009-02-13	2011-07-21	Boehringer Ingelheim International Gmbh	SGLT-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia
EP2429520A1 (en)	2009-05-14	2012-03-21	Boehringer Ingelheim International GmbH	New combination therapy in treatment of oncological and fibrotic diseases
WO2010130758A1 (en) *	2009-05-14	2010-11-18	Boehringer Ingelheim International Gmbh	New combination therapy in treatment of cancer and fibrotic diseases
LT2451445T (lt)	2009-07-06	2019-06-25	Boehringer Ingelheim International Gmbh	Bibw2992, jo druskų ir kietų farmacinių kompozicijų, apimančių šį aktyvųjį ingredientą, džiovinimo būdas
JP2013512882A (ja)	2009-12-07	2013-04-18	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	トリプルネガティブ乳癌の治療に使用するｂｉｂｗ２９９２
CN102686581B (zh) *	2009-12-21	2015-08-26	张强	喹唑啉衍生物
US20120107304A1 (en)	2010-04-27	2012-05-03	Boehringer Ingelheim International Gmbh	Combination therapy in treatment of oncological and fibrotic diseases
US20130289056A1 (en)	2010-08-26	2013-10-31	Boehringer Ingelheim International Gmbh	Methods of administering an egfr inhibitor
KR20130105675A (ko) *	2010-11-25	2013-09-25	라티오팜 게엠베하	아파티닙의 신규 염 및 다형
WO2012122058A2 (en)	2011-03-04	2012-09-13	Newgen Therapeutics, Inc.	Alkyne substituted quinazoline compound and methods of use
CN102918029B (zh) *	2011-05-17	2015-06-17	江苏康缘药业股份有限公司	4-苯胺-6-丁烯酰胺-7-烷醚喹唑啉衍生物及其制备方法和用途
US8828391B2 (en)	2011-05-17	2014-09-09	Boehringer Ingelheim International Gmbh	Method for EGFR directed combination treatment of non-small cell lung cancer
CN102838590B (zh) *	2011-06-21	2014-07-09	苏州迈泰生物技术有限公司	氨基喹唑啉衍生物及其在制备抗恶性肿瘤药物中的用途
WO2013052157A1 (en)	2011-10-06	2013-04-11	Ratiopharm Gmbh	Crystalline forms of afatinib di-maleate
CN103073539B (zh) *	2011-10-26	2016-05-11	齐鲁制药有限公司	4-(取代苯氨基)喹唑啉衍生物及其制备方法、药物组合物和用途
ME02648B (me)	2012-01-17	2017-06-20	Astellas Pharma Inc	Jedinjenje pirazin karboksamida
CN103772380A (zh) *	2012-10-23	2014-05-07	杨子娇	一类治疗房角狭窄的化合物及其用途
JP2016511754A (ja)	2013-02-01	2016-04-21	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	放射性標識キナゾリン誘導体
PT2981271T (pt)	2013-04-05	2019-02-19	Boehringer Ingelheim Int	Utilizações terapêuticas de empagliflozina
US11813275B2 (en)	2013-04-05	2023-11-14	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
HK1213818A1 (zh)	2013-04-05	2016-07-15	勃林格殷格翰国际有限公司	依帕列净的治疗用途
CA2812519A1 (en)	2013-04-05	2014-10-05	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
EA033286B1 (ru)	2013-04-18	2019-09-30	Бёрингер Ингельхайм Интернациональ Гмбх	Способ лечения или отсрочки развития хронической болезни почек
CN103254183B (zh) *	2013-05-10	2015-11-11	苏州明锐医药科技有限公司	阿法替尼的制备方法
CN103254182A (zh) *	2013-05-10	2013-08-21	苏州明锐医药科技有限公司	一种阿法替尼的制备方法
WO2014180271A1 (zh) *	2013-05-10	2014-11-13	苏州明锐医药科技有限公司	阿法替尼及其中间体的制备方法
WO2014183560A1 (zh) *	2013-05-16	2014-11-20	苏州明锐医药科技有限公司	阿法替尼及其中间体的制备方法
CN103242303B (zh) *	2013-05-16	2015-03-25	苏州明锐医药科技有限公司	阿法替尼的制备方法
CN104513229A (zh) *	2013-09-28	2015-04-15	正大天晴药业集团股份有限公司	喹唑啉衍生物及其制备方法
CN103755688B (zh) *	2013-12-24	2015-11-18	江苏奥赛康药业股份有限公司	一种阿法替尼化合物的制备方法
US9242965B2 (en) *	2013-12-31	2016-01-26	Boehringer Ingelheim International Gmbh	Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
WO2015103456A1 (en)	2014-01-02	2015-07-09	Teva Pharmaceuticals International Gmbh	Crystalline forms of afatinib di-maleate
CN105315263B (zh) *	2014-07-30	2018-11-27	正大天晴药业集团股份有限公司	阿法替尼中间体的合成方法
EP3023421A1 (en)	2014-11-21	2016-05-25	Sandoz Ag	Crystalline forms of afatinib dimaleate
CN105801568B (zh)	2015-01-15	2019-07-30	杭州普晒医药科技有限公司	阿法替尼一马来酸盐晶型及其制备方法和药物组合物
ES2775614T3 (es) *	2015-03-20	2020-07-27	Chai Tai Tianqing Pharmaceutical Group Co Ltd	Sales de derivado de quinazolina y método de preparación de las mismas
CN105175400B (zh) *	2015-09-29	2018-04-10	河北神威药业有限公司	一种阿法替尼中间体的制备方法
WO2017141271A1 (en) *	2016-02-17	2017-08-24	Sun Pharmaceutical Industries Ltd.	Stable pharmaceutical composition of afatinib
CN106442793B (zh) *	2016-10-21	2019-05-24	河北神威药业有限公司	一种制备阿法替尼的中间体及其对映异构体的检测方法
US20180125813A1 (en)	2016-11-10	2018-05-10	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
TWI808958B (zh)	2017-01-25	2023-07-21	美商特普醫葯公司	涉及二芳基巨環化合物之組合療法
JP2021506974A (ja) *	2017-12-18	2021-02-22	スターングリーン、インク．	チロシンキナーゼ阻害剤として有用なピリミジン化合物
CN110437163A (zh) *	2018-05-03	2019-11-12	斯特恩格林公司	作为酪氨酸激酶抑制剂的嘧啶类化合物
MX2021003517A (es)	2018-09-25	2021-08-16	Black Diamond Therapeutics Inc	Composiciones de inhibidor de tirosina quinasa, metodos de fabricacion y metodos de uso.
CN109265449B (zh) *	2018-11-07	2021-11-23	沈阳工业大学	Egfr和her2双靶点酪氨酸激酶抑制剂及制备方法和用途
EP3903828A4 (en)	2018-12-21	2022-10-05	Daiichi Sankyo Company, Limited	ANTIBODY-DRUG CONJUGATE AND KINAS INHIBITOR COMBINATION
CN109824657A (zh) *	2019-03-26	2019-05-31	石药集团中奇制药技术（石家庄）有限公司	一种二马来酸阿法替尼新晶型及其制备方法和应用
CA3150701A1 (en)	2019-08-15	2021-02-18	Black Diamond Therapeutics, Inc.	Alkynyl quinazoline compounds
CN110590682A (zh) *	2019-10-14	2019-12-20	重庆医科大学	一种制备阿法替尼杂质的方法以及制备的杂质
WO2021094379A1 (en)	2019-11-12	2021-05-20	Astrazeneca Ab	Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancer
KR20220130190A (ko)	2020-01-20	2022-09-26	아스트라제네카 아베	암 치료를 위한 표피성장인자 수용체 티로신 키나제 억제제
US20210369709A1 (en)	2020-05-27	2021-12-02	Astrazeneca Ab	EGFR TKIs FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
WO2023051687A1 (zh) *	2021-09-30	2023-04-06	北京赛特明强医药科技有限公司	一种喹唑啉类化合物、组合物及其应用
US20250205233A1 (en)	2022-03-31	2025-06-26	Astrazeneca Ab	Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors in combination with an akt inhibitor for the treatment of cancer
WO2023209086A1 (en)	2022-04-28	2023-11-02	Astrazeneca Ab	Bicyclic heteroaromatic compounds for treating cancer
KR20250006237A (ko)	2022-04-28	2025-01-10	아스트라제네카 아베	축합 바이사이클릭 헤테로방향족 화합물 및 암의 치료에서의 이의 용도
WO2023209088A1 (en)	2022-04-28	2023-11-02	Astrazeneca Ab	Bicyclic heteroaromatic compounds and their use in the treatment of cancer
WO2023209090A1 (en)	2022-04-28	2023-11-02	Astrazeneca Ab	Bicyclic heteroaromatic compounds and their application in the treatment of cancer
MA71241A (fr)	2022-06-27	2025-04-30	Astrazeneca Ab	Combinaisons impliquant des inhibiteurs de tyrosine kinase du récepteur du facteur de croissance épidermique pour traiter le cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ332119A (en) *	1996-04-12	2001-08-31	Warner Lambert Co	Quinazoline compounds which are irreversible inhibitors of tyrosine kinases
ZA986729B (en) *	1997-07-29	1999-02-02	Warner Lambert Co	Irreversible inhibitors of tyrosine kinases
ZA986732B (en) *	1997-07-29	1999-02-02	Warner Lambert Co	Irreversible inhibitiors of tyrosine kinases
ID29800A (id) *	1999-02-27	2001-10-11	Boehringer Ingelheim Pharma	Turunan-turunan 4-amino-kinazolin dan kinolin yang mempunyai efek inhibitor pada transduksi signal yang dimediasi oleh tirosin kinase
DE19908567A1 (de) *	1999-02-27	2000-08-31	Boehringer Ingelheim Pharma	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
DE19911366A1 (de) *	1999-03-15	2000-09-21	Boehringer Ingelheim Pharma	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
DE19911509A1 (de) *	1999-03-15	2000-09-21	Boehringer Ingelheim Pharma	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
MXPA01012899A (es) *	1999-06-21	2002-07-30	Boehringer Ingelheim Pharma	Heterociclos biciclicos, medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparacion.
ES2280375T3 (es) *	2000-04-08	2007-09-16	BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG	Heterociclos biciclicos, medicamentos que contienen estos compuestos, su uso y procedimiento para su preparacion.

2000
- 2000-12-20 DE DE10063435A patent/DE10063435A1/de not_active Withdrawn
2001
- 2001-12-12 WO PCT/EP2001/014569 patent/WO2002050043A1/de not_active Ceased
- 2001-12-12 SI SI200130916T patent/SI1345910T1/sl unknown
- 2001-12-12 HR HR20030504A patent/HRP20030504B1/xx not_active IP Right Cessation
- 2001-12-12 BR BRPI0116266A patent/BRPI0116266B8/pt not_active IP Right Cessation
- 2001-12-12 ME MEP-2008-595A patent/ME02777B/me unknown
- 2001-12-12 DK DK01271363T patent/DK1345910T3/da active
- 2001-12-12 CN CNB018208665A patent/CN1277822C/zh not_active Expired - Lifetime
- 2001-12-12 IL IL15627701A patent/IL156277A0/xx unknown
- 2001-12-12 EP EP01271363.2A patent/EP1345910B9/de not_active Expired - Lifetime
- 2001-12-12 ES ES01271363T patent/ES2326617T3/es not_active Expired - Lifetime
- 2001-12-12 KR KR1020037008246A patent/KR100852102B1/ko not_active Expired - Lifetime
- 2001-12-12 AU AU2002219174A patent/AU2002219174B2/en active Active
- 2001-12-12 EE EEP200300300A patent/EE05244B1/et active Protection Beyond IP Right Term
- 2001-12-12 JP JP2002551540A patent/JP3827641B2/ja not_active Expired - Lifetime
- 2001-12-12 DE DE50114874T patent/DE50114874D1/de not_active Expired - Lifetime
- 2001-12-12 HU HU0301852A patent/HU228874B1/hu active Protection Beyond IP Right Term
- 2001-12-12 PL PL361798A patent/PL214798B1/pl unknown
- 2001-12-12 UA UA2003076821A patent/UA74614C2/uk unknown
- 2001-12-12 CZ CZ20031930A patent/CZ302721B6/cs not_active IP Right Cessation
- 2001-12-12 EA EA200300671A patent/EA006317B1/ru not_active IP Right Cessation
- 2001-12-12 MX MXPA03005559A patent/MXPA03005559A/es active IP Right Grant
- 2001-12-12 CA CA002432428A patent/CA2432428C/en not_active Expired - Lifetime
- 2001-12-12 SK SK771-2003A patent/SK287573B6/sk not_active IP Right Cessation
- 2001-12-12 AU AU1917402A patent/AU1917402A/xx active Pending
- 2001-12-12 AT AT01271363T patent/ATE430136T1/de active
- 2001-12-12 RS YUP-496/03A patent/RS50860B/sr unknown
- 2001-12-12 PT PT01271363T patent/PT1345910E/pt unknown
- 2001-12-12 NZ NZ526918A patent/NZ526918A/en not_active IP Right Cessation
- 2001-12-12 EP EP09158964A patent/EP2112140A1/de not_active Withdrawn
- 2001-12-17 UY UY27078A patent/UY27078A1/es not_active Application Discontinuation
- 2001-12-19 MY MYPI20015767A patent/MY136086A/en unknown
- 2001-12-19 AR AR20010105883A patent/AR040524A1/es active IP Right Grant
- 2001-12-19 TW TW090131520A patent/TWI295992B/zh active
2003
- 2003-05-28 ZA ZA200304141A patent/ZA200304141B/en unknown
- 2003-06-03 IL IL156277A patent/IL156277A/en active Protection Beyond IP Right Term
- 2003-06-16 NO NO20032726A patent/NO325672B1/no active Protection Beyond IP Right Term
- 2003-06-19 BG BG107929A patent/BG66139B1/bg unknown
2009
- 2009-07-23 CY CY20091100793T patent/CY1109290T1/el unknown
2014
- 2014-01-30 FR FR14C0009C patent/FR14C0009I2/fr active Active
- 2014-01-31 LU LU92370C patent/LU92370I2/fr unknown
- 2014-02-06 LT LTPA2014005C patent/LTC1345910I2/lt unknown
- 2014-02-11 NO NO2014003C patent/NO2014003I2/no not_active IP Right Cessation
- 2014-02-12 HU HUS1400005C patent/HUS1400005I1/hu unknown
- 2014-02-12 CY CY2014008C patent/CY2014008I2/el unknown
- 2014-02-18 BE BE2014C009C patent/BE2014C009I2/fr unknown
2022
- 2022-07-01 NO NO2022028C patent/NO2022028I1/no unknown

Also Published As

Publication number	Publication date
TWI295992B (en)	2008-04-21
DE50114874D1 (de)	2009-06-10
IL156277A (en)	2009-12-24
NO2022028I1 (no)	2022-07-01
NO20032726L (no)	2003-06-16
EP1345910B9 (de)	2014-06-04
HK1060571A1 (en)	2004-08-13
CN1277822C (zh)	2006-10-04
KR20030071787A (ko)	2003-09-06
ZA200304141B (en)	2004-04-15
WO2002050043A1 (de)	2002-06-27
ES2326617T9 (es)	2014-09-10
UA74614C2 (en)	2006-01-16
EP2112140A1 (de)	2009-10-28
HUS1400005I1 (hu)	2017-08-28
LU92370I9 (et)	2019-01-17
NO325672B1 (no)	2008-07-07
EP1345910A1 (de)	2003-09-24
JP2004516283A (ja)	2004-06-03
FR14C0009I1 (fr)	2014-03-07
YU49603A (sh)	2006-05-25
ME02777B (me)	2011-10-10
JP3827641B2 (ja)	2006-09-27
BRPI0116266B1 (pt)	2017-10-31
CA2432428A1 (en)	2002-06-27
CN1481370A (zh)	2004-03-10
UY27078A1 (es)	2002-07-31
RS50860B (sr)	2010-08-31
KR100852102B1 (ko)	2008-08-13
CZ302721B6 (cs)	2011-09-21
PT1345910E (pt)	2009-07-14
LTC1345910I2 (lt)	2022-06-10
HUP0301852A3 (en)	2008-03-28
PL214798B1 (pl)	2013-09-30
NO2014003I2 (no)	2015-10-19
BR0116266A (pt)	2004-02-17
NO20032726D0 (no)	2003-06-16
EA006317B1 (ru)	2005-10-27
CZ20031930A3 (cs)	2003-10-15
EP1345910B1 (de)	2009-04-29
FR14C0009I2 (fr)	2014-11-14
HUP0301852A2 (hu)	2003-09-29
AU1917402A (en)	2002-07-01
ES2326617T3 (es)	2009-10-16
LU92370I2 (fr)	2014-03-31
EE05244B1 (et)	2009-12-15
HU228874B1 (en)	2013-06-28
DE10063435A1 (de)	2002-07-04
SK287573B6 (sk)	2011-03-04
AR040524A1 (es)	2005-04-13
MY136086A (en)	2008-08-29
BRPI0116266B8 (pt)	2021-07-27
CY2014008I2 (el)	2015-12-09
BE2014C009I2 (et)	2021-02-04
EA200300671A1 (ru)	2004-06-24
MXPA03005559A (es)	2004-10-14
SI1345910T1 (sl)	2009-08-31
HRP20030504A2 (en)	2005-06-30
AU2002219174B2 (en)	2007-09-06
HRP20030504B1 (en)	2011-09-30
BG107929A (bg)	2005-01-31
CY2014008I1 (el)	2014-07-02
LTPA2014005I1 (lt)	2022-05-25
NZ526918A (en)	2006-11-30
PL361798A1 (en)	2004-10-04
CY1109290T1 (el)	2014-07-02
SK7712003A3 (en)	2003-10-07
CA2432428C (en)	2009-09-01
DK1345910T3 (da)	2009-07-20
BG66139B1 (bg)	2011-07-29
IL156277A0 (en)	2004-01-04
ATE430136T1 (de)	2009-05-15
NO2014003I1 (no)	2014-06-02
MEP59508A (en)	2011-05-10

Publication	Publication Date	Title
EE200300300A (et)	2003-10-15	Kinasoliinderivaadid, neid ühendeid sisaldavad ravimid, nende kasutamine ja meetod nende valmistamiseks
EE200300077A (et)	2004-12-15	Bitsüklilised heterotsüklilised ühendid, neid ühendeid sisaldavad ravimid, nende kasutamine ja meetodid nende valmistamiseks
EE9800277A (et)	1999-02-15	4-aminopürimidiinderivaadid, neid ühendeid sisaldavad ravimid, nende kasutamine ja meetod nende valmistamiseks
EE200100695A (et)	2003-02-17	Bitsüklilised heterotsüklilised ühendid, neid ühendeid sisaldavad ravimid, nende kasutamine ja meetodid nende valmistamiseks
EE200100431A (et)	2002-12-16	16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
NO20032733L (no)	2003-08-14	Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
EE05240B1 (et)	2009-12-15	Orto- ja meta-asendatud bisarlhendid, nende kasutamine ja neid sisaldavad farmatseutilised preparaadid
NO20024175D0 (no)	2002-09-02	Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
NO20032735L (no)	2003-08-06	Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
EE05134B1 (et)	2009-02-16	Adamantaani derivaadid, meetod nende valmistamiseks, neid sisaldavad ravimkoostised ja nende kasutamine ravis
EE200200369A (et)	2003-10-15	Asendatud piperidiinid, neid ühendeid sisaldavad ravimid ja meetodid nende valmistamiseks
EE200200095A (et)	2003-04-15	Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod
EE05183B1 (et)	2009-06-15	Asabitsklilised hendid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
NO20021719L (no)	2002-04-11	6-posisjon substituerte indoliner, fremstilling og anvendelse derav som medikament
EE200300327A (et)	2003-10-15	Uurea derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutiline kompositsioon
EE200200149A (et)	2003-04-15	Kinasoliinühendid ja neid sisaldavad ravimkoostised
NO20011216L (no)	2001-05-09	Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene
EE04527B1 (et)	2005-08-15	Aromaatsed heterotsüklilised ühendid, nende kasutamine ja meetodid nende valmistamiseks
NO20025879D0 (no)	2002-12-06	Acylfenylureaderivater, fremgangsmåte for fremstilling derav og deres anvendelse som et legemiddel
AU2001284021A1 (en)	2002-03-13	Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof
EE200100684A (et)	2003-04-15	Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200300254A (et)	2003-12-15	Heterotsüklilised ühendid, millel on antibakteriaalne toime, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
EE04721B1 (et)	2006-10-16	Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
EE200200041A (et)	2003-04-15	Karboksüülhappeamiidid, neid ühendeid sisaldavad ravimid, nende kasutamine ja valmistamine
EE200300245A (et)	2003-08-15	Bensotiofeeni derivaadid, nende valmistamise meetod ja kasutamine

Legal Events

Date	Code	Title	Description
2009-10-15	HB1A	Correction of owner name or address
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231
2014-04-15	AA1Y	Spc filed	Free format text: PRODUCT NAME: AFATINIIB;REG NO/DATE: K(2013)6342 (LOPLIK) 25.09.2013 Spc suppl protection certif: C20140003 Filing date: 20140213
2014-06-16	FG1Y	Spc granted	Free format text: PRODUCT NAME: AFATINIIB;REG NO/DATE: K(2013)6342 (LOPLIK) 25.09.2013 Spc suppl protection certif: C20140003 00098 Filing date: 20140213 Extension date: 20261212
2022-06-15	SPCT	Party data change related to a supplementary protection certificate	Spc suppl protection certif: 00098
2022-11-15	SPCZ	Extension of supplementary protection certificate: granted [paediatric extension]	Free format text: PRODUCT: AFATINIIB Spc suppl protection certif: C20140003 Extension date: 20270612